StockStory.org on MSN
Medical devices & supplies - specialty stocks Q1 teardown: Bausch + Lomb (NYSE:BLCO) vs the rest
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
Glaukos, a medical technology company focusing on eye disorders, has achieved gains of 20% year to date and 48% over the last ...
Unlike traditional software systems that rely on deterministic rules, artificial intelligence devices frequently use ...
Paragon Health Institute, a leader in health care research and market-based policy reforms, has published Generalization Uncertainty in AI-Enabled Medical Devices: A Safer Way Forward, a major ...
Medical devices have existed in some form for centuries, resulting in thousands of innovative implementations over the years. Throughout history, medical devices have addressed a wide array of disease ...
The idea of a medical device that is fully recyclable or completely biodegradable appeals to many in the industry – even patients. Although progress has been slow, the medical device industry is ...
The Food and Drug Administration designates as “breakthrough” technologies certain drugs and devices. This designation helps expedite the development and review of therapies intended to treat serious ...
VElectrical safety class, EMC characterization, sensor architecture, and OEM compliance documentation are the variables that ...
Integer Holdings designs and manufactures advanced medical devices for global healthcare OEMs, serving diverse therapeutic markets.
Regulators increasingly want medical device manufacturers to begin with a more precise understanding of their product's ...
DUBLIN--(BUSINESS WIRE)--The "Global Medical Devices Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The global medical devices market attained a ...
GlobalData on MSN
OncoSil Medical secures TGA approval for pancreatic cancer device
The approval is expected to drive increased clinical adoption and support applications for regulatory approval in other markets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results